Home
Welcome
The Trinity Biomedical Sciences Institute (TBSI) is an environment where innovative and interdisciplinary approaches are leading to scientific discoveries of biomedical importance, ultimately giving rise to better patient care.
TBSI COVID-19 Plan
-
TBSI Covid-19 Planview TBSI Covid-19 Plan ." -
TBSI host November Conferenceview Poster ." -
Scientists based in TCD/TBSI are researching plants and microbes in soil and water for pharmaceuticals. -
Scientists blueprint bacterial enzyme believed to play “stealthy” role in suppressing immune response. -
Immunologists discover new trick used by MRSA superbug. -
Dr David Finlay teams up with ONK Therapeutics to seek improved cancer therapies. -
6 Irish start-ups taking to the virtual stage at BioEquity Europe. Great to see so many from TBSI involved.TCD spin-out Azadyne and Neuropath" -
Three Trinity researchers win European Research Council Advanced Grants.Congratulations to Danny Kelly (TBSI), one of the three recipients" -
Researchers investigate treatment of cancer cachexia in collaboration with Artelo Biosciences.Led by Richard K Porter, Associate Professor of Biochemistry & Immunology at TBSI" -
Two new potential therapeutic targets for rheumatoid arthritis.collaborative team led by Dr Achilleas Floudas and Professor Ursula FearonProfessor (pictured here)" -
Science Foundation Ireland 2020 Science Awards recognise key leaders in the Irish Research Community.SFI Researcher of the Year Award: Kingston Mills, SFI Outstanding Contribution to STEM communications: Luke O Neill" -
Is reaching zero COVID-19 possible?.by Kingston Mills" -
Landmark deal for UQ-Trinity inflammation startup.Uniquest news ."
